HUBEI BIOCAUSE PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.76 CNY | -2.76% |
|
-4.35% | -38.03% |
| 17/06 | Biocause Pharma Plans Buyback of Up to 100 Million Yuan Shares | MT |
| 29/04 | Hubei Biocause Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hubei Biocause Pharmaceutical Co.,Ltd. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The Company is also involved in pharmaceutical business and chemical business. The Companyâs products include polypropylene and Ibuprofen. The Company distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.
Sector
Life & Health Insurance
Calendar
01/07/2024
- Extraordinary Shareholders Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.03% | 1.2B | |
| +2.98% | 71.57B | |
| +8.07% | 50.66B | |
| +7.15% | 50.39B | |
| +23.94% | 47.42B | |
| +13.13% | 42.13B | |
| +21.96% | 38.53B | |
| +17.37% | 33.26B | |
| -2.49% | 28.37B | |
| +29.18% | 26.61B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Biocause Pharma Plans Buyback of Up to 100 Million Yuan Shares
